JS-K

• CAT Number: R066943
• CAS Number: 205432-12-8
• Molecular Formula: C13H16N6O8
• Molecular Weight: 384.30
• Purity: ≥95%
• Synonyms: 4-[2-(2,4-dinitrophenoxy)-1-oxidodiazenyl]-1-piperazinecarboxylic acid, ethyl ester
• Target: Apoptosis
• Storage: -20°C
• IUPAC Name: (Z)-(2,4-dinitrophenoxy)imino-(4-ethoxycarbonylpiperazin-1-yl)-oxidoazanium
• InChI: InChI=1S/C13H16N6O8/c1-2-26-13(20)15-5-7-16(8-6-15)19(25)14-27-12-4-3-10(17(21)22)9-11(12)18(23)24/h3-4,9H,2,5-8H2,1H3/b19-14-
• InChIKey: DNJRNBYZLPKSHV-RGEXLXHISA-N
• SMILES: O=[N](N1CCN(C(OCC)=O)CC1)=NOC(C=CC([N+]([O-])=O)=C2)=C2[N+]([O-])=O

JS-K (Cat.No:R066943) is a nitric oxide (NO)-releasing prodrug that is being studied for its potential therapeutic effects in cancer and other diseases. It selectively releases NO in cancer cells, leading to cell death while sparing normal tissues. JS-K is being investigated for its role in enhancing the efficacy of chemotherapeutic agents, treating metastatic cancer, and possibly targeting inflammatory diseases. Its unique mechanism of action as a NO donor makes it a promising candidate for cancer therapy and immunomodulation.